MoneyWorks4Me

Kwality Pharmaceuticals board to consider interim dividend

13 Dec 2016 Evaluate

Kwality Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled to be held on December 22, 2016, to consider the interim dividend for the financial year 2016-17. Further in accordance with the Company’s code of conduct for prevention of insider trading, the trading window will be closed with effect from December 13, 2016 till 48 hours from the conclusion of the meeting.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..